RCAG
AIMT

Rehmann Capital Advisory Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Rehmann Capital Advisory Group’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		$2.41K Buy
+115
New +$2.41K ﹤0.01% 1383
2018
Q4 		– Sell
-242
Closed -$6.6K – 2207
2018
Q3 		$6.6K Sell
242
-34
-12% -$927 ﹤0.01% 1495
2018
Q2 		$7.42K Buy
276
+34
+14% +$914 ﹤0.01% 1443
2018
Q1 		$8K Buy
+242
New +$8K ﹤0.01% 1399